Search Results - David A. Sandham
- Showing 1 - 2 results of 2
-
1
-
2
Fevipiprant (QAW039), a Slowly Dissociating CRTh2 Antagonist with the Potential for Improved Clinical Efficacy by David A. Sykes, Michelle Bradley, Darren Riddy, Elizabeth Willard, John Reilly, Asadh Miah, Carsten Bauer, Simon J. Watson, David A. Sandham, Gerald Dubois, Steven J. Charlton
Published 2016Artigo